Agilon Health

Agilon Health is facing a federal securities class action lawsuit due to allegedly making false and/or misleading statements regarding its 2025 guidance and the financial impact of its strategic actions. Its stock fell 51.5% on August 5, 2025, after suspending its full-year 2025 financial guidance.

Agilon Health is facing a class action securities lawsuit due to alleged false statements and concealment regarding its 2025 guidance and the financial impact of its strategic actions. This could lead to significant financial penalties and reputational damage for Agilon Health.

Agilon Health is facing a securities fraud class action lawsuit due to allegedly misleading investors about its 2025 guidance and the financial impact of its strategic actions. This could lead to significant financial penalties and reputational damage.

Agilon Health announced the resignation of its President, CEO, and Board Director Steven Sell, and simultaneously withdrew its full-year 2025 earnings guidance. This news led to a more than 27% drop in its share price during after-hours trading, indicating a significant negative impact on the company's market valuation and investor confidence.

Agilon Health is facing a securities class action lawsuit for allegedly making false and misleading statements regarding its 2025 guidance and the impact of its strategic actions. This could lead to significant financial penalties and reputational damage for the company.